Pulsed Field Ablation (PFA) System Market: Current Analysis and Forecast (2023-2030)

The pulsed field ablation (PFA) system market was valued at USD 100 Million in 2022 and is expected to grow a CAGR of 25.1% during the forecast period (2023-2030). The pulsed field ablation (PFA) system is a pioneering medical technology revolutionizing the treatment landscape for various cardiac arrhythmias and other medical conditions. PFA specializes in delivering controlled bursts of pulsed electric fields to achieve tissue ablation and minimize the risk of collateral damage to neighboring tissues. Pulsed field ablation (PFA) system services mainly gained prominence due to the rising number of cardiovascular disease cases. For instance, according to the U.S. Department of Health & Human Services in 2021, about 1 in 20 adults aged 20 and older had cardiovascular disorder (about 5%).  There has been a significant rise in the market due to this driving factor. In addition to this, investments in healthcare departments and government awareness programs regarding chronic diseases have increased significantly in recent years, which are the key factors creating opportunities for the market.

Boston Scientific Corporation; Kardium; Abbott; Galvanize Therapeutics, Inc.; MIRAI MEDICAL; Pulse Biosciences, Inc.; AccuPulse Medical; Acutus Medical, Inc.; CathRx Ltd.; AccuPulse Medical are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst therapeutic area, oncological disorders category to witness higher CAGR during the forecast period”

Based on therapeutic areas, the market is segmented into cardiovascular disorders, oncological disorders, respiratory disorders, and others. The oncological disorders segment is expected to grow with a high CAGR during the forecast period because of the rising liver cancer cases. For instance, according to the American Cancer Society, more than 800,000 people are diagnosed with liver cancer each year throughout the world. PFA is a relatively new technology that offers promising results in terms of efficacy and safety compared to traditional ablation methods. Thus, oncological disorders are expected to witness a higher CAGR during the forecast period.

“Amongst product components, catheters held a significant share in the market in 2022”

Based on product components, the market is bifurcated into catheters and generators. The catheters segment is dominating the market owing to the advanced features like easier pulmonary vein isolation performed by the catheters. Catheters are a critical component of PFA systems, as they deliver the pulsed electric fields to target tissues during the ablation procedure. Advancements in catheter technology, such as enhanced tissue contact, and better mapping capabilities, have contributed to the increasing adoption of PFA systems. For instance, in January 2024, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the FARAPULSE™ Pulsed Field Ablation (PFA) System which has an advanced catheter named FARAWAVE™ PFA Catheter which is designed to treat a range of pulmonary vein anatomies using an over-the-wire catheter with variable distal shapes (basket and flower). Furthermore, the growing demand for minimally invasive treatment options has fueled the expansion of the catheter segment within the PFA system market. Thus, catheters held a significant share in the market in 2022.

“Amongst application area, ablation & mapping category to witness higher CAGR during the forecast period”

Based on application area, the market is bifurcated into ablation and ablation & mapping. The ablation & mapping segment is expected to grow with a high CAGR during the forecast period because of the advanced features offered by the device. Features such as continually recording and displaying the electrical activity of the atrium expanded the scope of applications and have contributed to the growth of the ablation and mapping segment. There has been a corresponding rise in the adoption of these systems for ablation and mapping procedures. The ablation and mapping segment in the PFA system market is expected to continue growing as technological advancements drive improvements in treatment outcomes and expand the scope of applications. For instance, in December 2023, Medtronic received FDA approval for its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation. It is a cardiac ablation system that enables both mapping and precise lesion delivery using biphasic waveform optimization. Thus, ablation & mapping are expected to witness a higher CAGR during the forecast period.

“Amongst regions, North America held a significant share in the market in 2022”

North America is dominating the market in the current scenario of 2022 due to the rising number of investments in developing effective pulsed field ablation (PFA) systems. Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Continuous innovations including improvements in catheter design, generator capabilities, and mapping techniques, have enhanced the efficacy and safety of ablation procedures, driving increased adoption in North America. North America has a relatively high prevalence of cardiac arrhythmias such as atrial fibrillation. For instance, according to the U.S. Department of Health & Human Services, it is estimated that 12.1 million people in the U.S. will have atrial fibrillation in 2030. As the population ages and risk factors such as obesity and hypertension become more prevalent, the demand for effective treatment options like PFA systems has potentially risen. The well-established healthcare infrastructure in North America, including advanced hospitals and medical centers, supports the adoption and utilization of innovative medical technologies. Thus, amongst regions, North America held a significant share of the market in 2022.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.


• The report presents a quick review of overall industry performance at one glance.


• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.


• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.


• The study comprehensively covers the market across different segments.


• Deep dive regional level analysis of the industry.

Customization Options:

The global pulsed field ablation (PFA) systems market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.